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Introduction
Efforts aimed at primary and secondary prevention of cardiovascular disease, the major killer of contemporary adult populations [1] [2] [3] , largely rely on modification of risk behaviours related to smoking, physical activity, dietary intake, and alcohol consumption 4, 5 . Control of obesity and hypertension, the interim risk states between health and disease, constitute another large part of preventive ventures.
In the public health that increasingly turns its attention toward genomics, the major challenge is to understand the role of genetic variants in susceptibility to chronic diseases and associated risk factors 6 . This has required characterising the nature of gene variation, assembling an extensive catalogue of single nucleotide polymorphisms (single base-pair mutations that occur at a specific site in the DNA sequence, SNPs) in candidate genes, and performing association studies and other gene mapping studies.
A step further, we need to incorporate findings from genomics into clinical and public health interventions. Beyond associations studied in classical epidemiologythose of behavioural risk factors and obesity phenotype 7 -as well as beyond the major genes that play a deciding role in monogenic obesity, such as is leptin deficiency for example, we were interested in SNPs -primary genetic information and primary variants where the genetic predisposition could be discovered -and their role in developing common obesity 8 . No single SNP will cause a complex trait; however, in a gene-environment interaction, a combination of variants exposed to what is often called 'obesogenic' environment will increase the relative risk that an individual develops the trait.
The extent to which this process is mediated by associations between particular SNPs and behavioural risk factors for overweight or obesity may determine opportunities for novel, personalised preventive interventions. Currently most effective interventions combine nutrition education and exercise counselling with behavioural strategies to improve a person's ability to lose weight 9, 10 . In other words, current interventions require that all people work on both sides of the intake-expenditure energy equation. Such one-size-fits-all approach has not reaped much success in controlling the burden of obesity. Alternatively, personalised prevention strategies might be able to identify people who are more likely to benefit from focusing on one or the other side of the energy equation, as well as people who are more likely to lose weight in response to certain macronutrient diet compositions (e.g., low-fat or low-carbohydrate diet).
Objectives
In the informational abundance of over 10 million human SNPs that are currently listed in publicly accessible databases 11 , we aimed to identify SNPs that are linked both with increased body weight and behavioural risk factors for this trait, thus holding promise for future design of personalised behaviourally based preventive interventions to reduce obesity.
Methods
In the initial search, the results of which have previously been communicated 12 , we searched the Cochrane Database of Systematic Reviews, MEDLINE, INSPEC, Current Contents, and Cochrane Controlled Trials Register for abstracts of surveys published to December 2008 in any language, which had examined the associations between any SNPs and behaviours implicated in the aetiology of human obesity, namely physical activity, smoking, diet, alcohol consumption, and psychological stress. Two researchers checked all abstracts for eligibility and we included in both the previous and the current report only those articles that found significant associations between identified SNPs and one or more behaviours of interest. Animal studies were excluded.
For this report, we expanded the search to December 2009 using HuGE Navigator, an integrated knowledge base on human genome epidemiology 13 . HuGE Navigator is updated weekly from PubMed by means of an automatic literature screening program. A genetic epidemiologist selects abstracts that meet inclusion criteria and indexes them by gene, category, and study type. We searched HuGE Navigator's Phenopedia for gene-environment interaction articles with obesity and behaviours of interest as search terms.
Results
Our initial search returned 77 abstracts of which 18 were deemed eligible for inclusion (Tables 1 and 2 ). The HuGE Navigator search returned all but one abstracts identified in the initial search 14 , as well as 45 additional articles eligible for inclusion (Table 3 ). In total, gene-obesity-behaviour interactions were reported for 46 genes.
In one article, where 26 SNPs on the fat mass and obesity associated (FTO) gene were found to be associated with body mass index (BMI), two variants -rs1477196 and rs1861868 -were only associated with obesity in people with low levels of physical activity. No association between these two variants and BMI was found among people with above-average physical activity scores.
Another article indicated that alcohol consumption may play a protective mediating role in one variant's impact on glucose metabolism: in men, carriers of 14672C>G in the promoter region of hormone-sensitive lipase locus (LIPE) who did not drink alcohol had higher glucose levels A tagging SNP/tSNP, Ala484Thr (rs7498665) in the region encompassing the human SH2-B gene Ala484Thr (minor allele frequency 0.38) was associated with serum leptin, total fat, waist circumference, and body weight than non-carriers, but there were no differences among people who do drink alcohol. In the oxodeoxyguanosine (OGG1) gene, variant Ser(326)Cys was found to be associated with the risk for breast cancer, but only among moderate alcohol drinkers, while another variant in the same gene -11657A/G -was associated with increased body weight.
Variants in the myotublarin-related protein 9 (MTMR9) gene, SLC6A14 gene, and SH2-B gene showed the potential to affect control of appetite.
A number of articles implicated various SNPs, located on several genes, in changing carriers' response to diet. In the TUB gene, for example, AG heterozygote and AA homozygote of the rs2272382 derived less energy from fat, and both were associated with increased energy intake from carbohydrates. Both rs22728133 and rs1528133 were also associated with higher glycaemic load in the diet, which was higher than glycaemic load among the wild types. Concerning the APO gene, among people with APOA5-1131T (major allele) the BMI increased with higher fat intake; however, in APOA5-1131C (minor allele) no increase was seen in BMI with increased fat consumption. Carriers of APOA5-1131C minor allele had a lower risk for overweight and obesity, but not when fat intake was low.
UCP-3 was exposed as an anti-thrifty gene that dissipates energy as heat and prevents obesity, while variants in the adiponectin gene had an impact on insulin resis- The Arg allele carriers of the Lys109Arg LEPR gene polymorphism were associated with an increased proinflammatory state and stress condition at baseline. These obesity-related markers were importantly decreased after an 8-week energy-restricted (hypocaloric) diet (-30% E) diet Genetic variation in the UCP2-UCP3 gene cluster may act as a modifier increasing serum lipid levels and indices of abdominal obesity, and may thereby also contribute to the metabolic aberrations observed in obesity and type 2 diabetes tance. In the initial report of the RIVAGE study, some SNPs showed interactions with a metabolic response to diet (through ApoE and LDL-cholesterol and triacylglycerols, apoA-IV and LDL cholesterol, MTP and LDL-cholesterol, intestinal fatty acid-binding protein, and triacylglycerols). Ethnic specific and region specific responses, possibly related to diet, were shown to be mediated by several SNPs in the human integrin beta 2 subunit (ITGB2) gene, the diacylglycerol acyltransferase (DGAT) gene, as well as thrifty genes FABP", MTP, CAL10, beta 3AR, apo-E, UCP2, UCP3-p, PPARgama2, and LEPR.
None of the abstracts reported on a link between any SNPs and smoking, whereas psychological stress was only mentioned in one article, where it was reported to have been reduced following an 8-week hypocaloric diet.
Studies identified through HuGE Navigator fell in one of three categories, where SNPs were linked with increased body weight and either physical activity, diet characteristics, or some type of a mixed intervention aimed at reducing body weight, which invariably combined modification of both physical activity and dietary habits.
Physical activity extended an exacerbated protective effect on body weight or metabolic events when coupled with several polymorphisms in the BAR-2, FTO, MC4R, LIPE, GNB3, UCP3, and the PPARG gene. An exception was the ADRA2B gene where, in a Chinese population, the D allele conferred a favourable anthropometric and metabolic profile, especially when combined with lower levels of physical activity.
Some studies found gene-obesity-diet interactions. Carriers of GNB3 C825T seem to feel mental discomfort when fasting, which may explain their increased susceptibility towards increased body weight. The 11391/A allele in the adiponectin gene may protect from weight regain after a low-calorie dietary intervention. A low-calorie diet also seems to be a good choice for carriers of CB1, NPY, 420C>G polymorphisms in the resistin gene: allele carriers had a better response to the dietary regimen in terms of weight loss and metabolic changes, when compared to wild type participants.
In one study, a minor allele in the rs894160 on the PLIN gene was associated with additional weight gain, but only combined with low intake of carbohydrates; when coupled with higher intake of complex carbohydrates, the allele seems to have played a protective role against obesity. Another study found that both carriers of wild type and mutant alleles on the Lys656Asn locus in the LEPR gene lost weight in response to a low-fat, as well as a low-carbohydrate diet. However, only wild type Increased body weight in carriers of the risk allele of FTO SNP rs8050136 is a consequence of increased food intake, but not of impaired energy expenditure carriers had lower leptin concentrations, which was seen with both tested diets.
A hypocaloric diet seems to work well for people with the -55CT polymorphism of the UCP3 gene, whereas having the PPARgamma Pro(12)Ala SNP may confer resistance to a low-calorie diet. On the contrary, the C allele of the PPARgamma-2-174G>C SNP seems to protect against regain of lost weight, and this effect is further strengthened by the presence of the Ala allele of the PPARgamma-2. Another study found that some CPT1 variants may modify body weight response to fat intake.
Several genotype-by-nutrient interactions were confirmed in a study of 549 obese European women. Although the study tested 42 polymorphisms in 26 candidate genes, the only tests that yielded statistical significance were for the interaction between fiber intake and the -514 C > T polymorphism of the LIPC gene, as well as those for fat intake and -11377G > C polymorphism of the ADIPOQ gene and the -681 C > G polymorphism of the PPARG3 gene.
Carriers of the minor allele PLIN11482A showed resistance to weight loss after a 1-year low-energy dietary program. Women with APOE4 allele benefit the most from a low-fat, low-cholesterol diet, whereas the lipid profile could worsen in women without the APOE4 allele.
Finally, response to complex interventions that include advice on both diet and physical activity may be hampered or facilitated by various SNPs in the UCP2, UCP3, AGT, LEPR, FABP2, beta(3)AR, TNF-alpha, FTO, and INSIG2 genes.
Discussion
We have identified in the literature a number of SNPs that may be associated with increased risk for overweight or obesity and also with behavioural risk factors for these traits. With the advent of personalised health care, results of SNP genotyping are likely to start guiding personalised prevention of complex diseases in the near future.
Personalised prevention of obesity may develop twofold: as behaviourally based or pharmacogenomic approaches. Based on our findings, it is imaginable that, for example, carriers of rs1477196 and rs1861868 in the FTO gene would need to be advised to make sure they kept physically active above levels recommended for the general population, as this may protect them from excess weight. Carriers of P129T polymorphism in fatty acid amide hydrolase and carriers of APOA5-1131T>C polymorphism may need to be advised to opt for low-fat diets, whereas low-energy diets may prove a better choice for carriers of ht1 on the UCP-3 gene, carriers of A-3826G, A-1766G, and G+1068A on the UCP-1 gene, and carriers of 276G>T at the ADIPOQ gene. APOA5-1131T>C polymorphism is of particular interest and preventive potential, due to its high prevalence of 13% in the studied population.
These and most probably other SNPs hold promise for future design of personalised behaviourally based interventions for preventing obesity. However, we are still in the discovery phase of genomics obesity research 15 . Most of the gene-environment-behaviour interactions explored in this paper have only been tested in a single study. Moreover, studies are often poorly described and lack methodological detail necessary for critical appraisal; samples are often small, include healthy volunteers, or no information is given on the selection process; analysis frequently fails to account for multiple testing, and only some studies report the proportion of variance explained by any given gene variant. Indeed, more than half of the obesity related genes in the HuGE Navigator's Phenopedia have only been implicated in a single study thus far. It is likely that many of these associations may be rejected in future replication studies.
We believe now is the time to help obesity genomics on the long road towards effective clinical and public health interventions, not least by developing reporting standards -which are lacking for this field of research. This gap has been somewhat filled while our paper was under review 16 . Some of the included studies reported sufficient information on markers (including i.e. rs code for SNP markers, which are widely accepted unique SNP identifiers), while some reported SNP or other descriptions in a non-standardised way. Results were not always clearly stated, especially in the articles covering gene--obesity-diet interactions.
These issues made us consider and investigate the feasibility of using some of the existing standards. Although a number of relevant attempts have been made, including the GO ontology and several applications that use the XML language, we could not identify any applications that could fit the available data from the included studies, which are commonly reporting a simple association of a genetic marker with some phenotypic trait or a disease.
Given the already large number of studies reporting on gene-obesity-behaviour interactions, an enormous potential for similar future work, as well as the relevance of this line of research for population health, it would seem prudent to consider developing a specific reporting standard for these studies. At the very least, following the reporting practice developed for other study designs (e.g. CONSORT for clinical trials), we would argue in favour of stating the study design as part of the title, as well as introducing a structured abstract that would include the information on a unique SNP identifier (rs code), effect allele, physical SNP location (usually defined as the number of base pairs from the chromosome start), chromosome, gene name, analysed trait, information on possible effect modifiers (i.e., adjustment for age and sex, other confounders, multivariate methods), proportion of variance, and other information. The application and use of such structured reporting format would likely enable creation of more informative, perhaps even entirely computer-generated summary reports. Establishing a vocabulary consensus in describing elements of study and data, for the purpose of annotation and integration, would also be a valuable contribution to the field.
As we contemplate what effects genetic testing, once widely available, might have on people's motivation to lose weight or the public's readiness to accept the new realities or, indeed, what new types of obesity might soon become definable in the disease categorisation of the genomic era, some improvement in the scientific communication to help us get there faster seems advisable. This seems in tune with views of others previously expressed in this journal 17 .
Strengths and limitations
We have conducted a comprehensive search across multiple databases and present in one place current state of the evidence relevant to the development of future behaviourally based obesity prevention strategies. However, we did not hand search the references in the included articles and it is possible that some published studies escaped our search strategy. Furthermore, we did not perform a formal assessment of the quality of the included studies, as we felt this was beyond the scope of the paper. Finally, we have not attempted to synthesise the findings at this stage, due to the heterogeneity of the included studies.
Conclusions
Personalisation of behaviourally based preventive approaches against obesity seems feasible in the near future. Automation of search algorithms, as well as development of more efficient tools for knowledge synthesis of genomic research into gene-obesity-behaviour interactions might facilitate the advent of widely available personalised prevention strategies. As a small step forward, we propose that structured standards of reporting specific to the field be developed as soon as possible, so as not to unnecessarily delay translation of these burgeoning findings into clinical and public health practice. In addition, our future efforts shall concentrate on developing a research repository dedicated to the use of public health genomics for obesity control.
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